Table 3.

Expression of 18S rRNA related to GAPDH in three BM subsets in diseased and control samples

BM cell population	Sample identification	18S rRNA, average CT	GAPDH, average CT	ΔCT 18S rRNA- GAPDH	ΔΔCT (ΔCT − ΔCT,C)	18S rRNA relative to GAPDH (2−ΔΔCT)
P	(C3, C5, C6)	20.60 ± 0.48	21.83 ± 0.32	−1.24 ± 0.58	0.00 ± 0.58	1.0 (0.67–1.49)
	D2	19.54 ± 0.49	22.69 ± 0.028	−3.155 ± 0.49	−1.91 ± 0.49	3.76 (2.68–5.27)
	D3	19.12 ± 0.07	23.20 ± 0.15	−4.075 ± 0.17	−2.83 ± 0.17	7.11 (6.32–8.00)
E	(C1, C3–C6)	18.46 ± 0.87	21.16 ± 0.37	−2.70 ± 0.95	0.00 ± 0.95	1.0 (0.52–1.93)
	D2	16.75 ± 0.00	20.03 ± 0.03	−3.28 ± 0.03	−0.58 ± 0.03	1.49 (1.46–1.52)
	D3	17.13 ± 0.07	21.89 ± 0.02	−4.76 ± 0.07	−2.06 ± 0.07	4.16 (3.97–4.37)
M	(C1, C3–C6)	16.38 ± 1.49	19.91 ± 0.99	−3.53 ± 1.78	0.00 ± 1.78	1.0 (0.29–3.43)
	D2	17.30 ± 0.98	21.06 ± 0.63	−3.76 ± 1.16	−0.23 ± 1.16	1.17 (0.52–2.62)
	D3	19.36 ± 0.64	22.48 ± 0.28	−3.12 ± 0.69	0.39 ± 0.69	0.76 (0.47–0.81)

Abbreviations: BM, bone marrow; C, control sample; C_T, number of cycles; C_T,_C, number of control cycles; D2, diseased 2; D3, diseased 3; E, erythroid progenitor; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; M, myeloid progenitor; P, multipotential progenitor.